The estimated Net Worth of David C Hohn is at least $30.4 millier dollars as of 2 July 2012. David Hohn owns over 1,000 units of Cytocom Inc stock worth over $30,381 and over the last 13 years David sold CBLI stock worth over $0.
Sign up
David Hohn CBLI stock SEC Form 4 insiders trading
David has made over 4 trades of the Cytocom Inc stock since 2011, according to the Form 4 filled with the SEC. Most recently David bought 1,000 units of CBLI stock worth $1,610 on 2 July 2012.
The largest trade David's ever made was buying 1,000 units of Cytocom Inc stock on 2 July 2012 worth over $1,610. On average, David trades about 400 units every 27 days since 2011. As of 2 July 2012 David still owns at least 9,584 units of Cytocom Inc stock.
You can see the complete history of David Hohn stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
What's David Hohn's mailing address?
David's mailing address filed with the SEC is C/O CLEVELAND BIOLABS, INC., 73 HIGH STREET, BUFFALO, NY, 14203.
Insiders trading at Cytocom Inc
Over the last 17 years, insiders at Cytocom Inc have traded over $1,157,190 worth of Cytocom Inc stock and bought 66,403 units worth $199,902 . The most active insiders traders include James Antal, Michael Fonstein et Bernard L Kasten. On average, Cytocom Inc executives and independent directors trade stock every 101 days with the average trade being worth of $21,921. The most recent stock trade was executed by Langdon L Miller on 22 July 2021, trading 10,000 units of CBLI stock currently worth $30,000.
What does Cytocom Inc's logo look like?
Complete history of David Hohn stock trades at Cytocom Inc
Cytocom Inc executives and stock owners
Cytocom Inc executives and other stock owners filed with the SEC include:
-
Christopher Zosh,
Interim Principal Executive Officer and Principal Financial Officer, Vice President of Finance -
Langdon Miller,
President, Chief Medical Officer -
Andrei Gudkov,
Chief Scientific Officer -
Lea Verny,
Independent Chairman of the Board -
Daniil Talyanskiy,
Independent Director -
Randy Saluck,
Independent Director -
Anna Evdokimova,
Independent Director -
Alexander Andryushechkin,
Independent Director -
Ivan Fedyunin,
Independent Director -
Anthony Principi,
Director -
C Neil Lyons,
Chief Financial Officer -
Elena Kasimova,
Director -
Yakov Kogan,
EVP of Bus. Development, Sec. -
Richard Mc Gowan,
Director -
James Antal,
Director -
Daniel Floyd Jr Hoth,
Director -
Julia R Brown,
Director -
Alexander Polinsky,
Director -
David C Hohn,
Director -
Bernard L Kasten,
Director -
Jean Viallet,
Chief Development Officer -
Paul E Di Corleto,
Director -
Michael Fonstein,
CEO & President -
Hector Daniel Perez,
Director -
John A Jr Marhofer,
Chief Financial Officer -
Securities Corp Sunrise,
10% owner -
Michael K Handley,
President and CEO -
Robert Buckheit,
Chief Technology Officer -
Cozette M. Mc Avoy,
Chief Legal Officer -
Clifford Selsky,
Chief Medical Officer -
Peter Aronstam,
Chief Financial Officer